Evidence map›Paper›PMID 29040704›Full record

ArticlePlant & cell physiology2017

In Planta Processing of the SpCas9-gRNA Complex.

Masafumi Mikami, Seiichi Toki, Masaki Endo

Open access · hybridAbstract read
In one paragraph

Article in Plant & cell physiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Review
  3. Building Blocks of Artificial CRISPR-Based Systems beyond Nucleases.International journal of molecular sciences · 2022
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Multiplexed Genome EditingFrontiers in plant science · 2021
    Article
  9. Article
  10. Applications of CRISPR-Cas in agriculture and plant biotechnology.Nature reviews. Molecular cell biology · 2020
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Masafumi MikamiGraduate School of Nanobioscience, Yokohama City University, 22- 2 Seto, Yokohama, Kanagawa 236-0027, Japan.
Seiichi TokiGraduate School of Nanobioscience, Yokohama City University, 22- 2 Seto, Yokohama, Kanagawa 236-0027, Japan.
Masaki EndoPlant Genome Engineering Research Unit, Institute of Agrobiological Sciences, National Agriculture and Food Research Organization, 2-1-2 Kannondai, Tsukuba, Ibaraki 305-8602, Japan.
National Agriculture and Food Research Organization · JPKihara Institute for Biological Research · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In CRISPR/Cas9 (clustered regularly interspaced short palindromic repeat/CRISPR-associated protein 9)-mediated genome editing in plants, Streptococcus pyogenes Cas9 (SpCas9) protein and the required guide RNA (gRNA) are, in most cases, expressed from a stably integrated transgene. Generally, SpCas9 protein is expressed from an RNA polymerase (pol) II promoter, while gRNA is expressed from a pol III promoter. However, pol III promoters have not been much characterized other than in model plants, making it difficult to select appropriate promoters for specific applications, while pol II transcripts have to be processed to generate functional gRNAs. Recently, successful processing of a pol II transcript into functional gRNAs using ribozyme or Csy4-RNA cleavage systems has been demonstrated. Here, we show that functional gRNAs can be efficiently processed using SpCas9 protein and plant endogenous RNA cleavage systems without the need for a specific RNA processing system. In our system, SpCas9 RNA and gRNA are both transcribed as a single RNA using a single pol II promoter; translated SpCas9 protein can be bound to this RNA and, finally, extra RNA sequences are trimmed by plant RNA processing systems to form a functional SpCas9-gRNA complex. The efficiency of targeted mutagenesis using our novel SpCas9-gRNA fused system was comparable with that of the SpCas9-gRNA system with ribozyme sequence, achieving rates of up to 100% in rice. Our results could be useful in developing stable SpCas9-gRNA expression systems and in RNA virus vector-mediated genome editing systems in plants.

Indexed as

ArabidopsisBacterial ProteinsCRISPR-Associated Protein 9CRISPR-Cas SystemsDNA Polymerase IIEndonucleasesMutagenesis, Site-DirectedMutationOryzaPlants, Genetically ModifiedPromoter Regions, GeneticRNA, CatalyticRNA, Guide, CRISPR-Cas SystemsBacterial ProteinsCas9 endonuclease Streptococcus pyogenesCRISPR-Associated Protein 9DNA Polymerase IIEndonucleasesRNA, CatalyticRNA, Guide, CRISPR-Cas SystemsCRISPR/Cas9RibozymeTargeted mutagenesis

Identifiers

PMID29040704
PMCPMC5921533
OpenAlexW2762222807

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.